HCAT - Health Catalyst - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HCAT is currently covered by 10 analysts with an average price target of $7.3. This is a potential upside of $4.65 (175.47%) from yesterday's end of day stock price of $2.65.

Health Catalyst's activity chart (see below) currently has 179 price targets and 125 ratings on display. The stock rating distribution of HCAT is 46.15% HOLD and 53.85% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 40% with an average time for these price targets to be met of 110.95 days.

Highest price target for HCAT is $10, Lowest price target is $5, average price target is $7.4.

Most recent stock forecast was given by ELIZABETH ANDERSON from EVERCORE on 07-May-2025. First documented stock forecast 18-Aug-2019.

Currently out of the existing stock ratings of HCAT, 6 are a HOLD (46.15%), 7 are a BUY (53.85%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$5

$2.04 (68.92%)

$4

5 months 3 days ago
(07-May-2025)

4/7 (57.14%)

$0.82 (19.62%)

53

Buy

$9

$6.04 (204.05%)

$11

5 months 3 days ago
(07-May-2025)

4/11 (36.36%)

$4.82 (115.31%)

96

Buy

$5

$2.2 (78.57%)

$9

5 months 24 days ago
(16-Apr-2025)

0/4 (0%)

$1.25 (33.33%)

Buy

$9

$6.04 (204.05%)

$13

6 months 28 days ago
(12-Mar-2025)

2/8 (25%)

$4.89 (118.98%)

331

Buy

$7

$4.04 (136.49%)

$12

7 months 7 days ago
(03-Mar-2025)

3/9 (33.33%)

$2.48 (54.87%)

269

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is HCAT (Health Catalyst) average time for price targets to be met?

On average it took 110.95 days on average for the stock forecasts to be realized with a an average price target met ratio 40

Which analyst has the current highest performing score on HCAT (Health Catalyst) with a proven track record?

STEVEN HALPER

Which analyst has the most public recommendations on HCAT (Health Catalyst)?

Steven Halper has 12 price targets and 7 ratings on HCAT

Which analyst is the currently most bullish on HCAT (Health Catalyst)?

Steven Halper with highest potential upside - $57.04

Which analyst is the currently most reserved on HCAT (Health Catalyst)?

Robert Jones with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?